sARS-cOv-2

SZ
by Steven Zuckerman2 views·Updated Aug 21, 2021

Chapters

Review of the review article in Continuum about COVId and nervous system complications.

Audio TranscriptAuto-generated

  1. Hello everybody.
  2. This is Stephen Zuckerman in baton rouge Louisiana and I'm
  3. going to give a presentation about the neurological manifestation of
  4. covid infections.
  5. I'm taking this information from a review article published in
  6. the most recent continuum and it was written by a
  7. doctor nath who was head of virology at the NIH.
  8. No other corona viruses have caused neurological effects.
  9. But the severe acute respiratory syndrome criminalized too with all
  10. of its mutations is more adept at replicating and adapting
  11. to humans.
  12. Now, when the pandemic first started, it seemed to me
  13. like neurologists were sort of reaching for neurological complications so
  14. they could be considered important in this horrible worldwide pandemic.
  15. But actually I was proven wrong and the nervous system
  16. is certainly part of the multi organ system involvement of
  17. this horrible condition.
  18. In fact no part of the nervous system is immune.
  19. That's my little dad pun from the potential effects of
  20. covid and these can occur even without any respiratory involvement.
  21. So let's take a look at what could cause or
  22. be caused by the coronavirus infection.
  23. And not only can we divide the different parts of
  24. the nervous system, central peripheral neuromuscular et cetera.
  25. They have different time courses in relationship two when the
  26. infection occurs.
  27. So there are power infectious syndromes and those are listed
  28. here and there are post infectious syndromes which for the
  29. most part are immune mediated.
  30. So we're going to go over the individual ones and
  31. see what sense we can make out of this.
  32. So the power infectious syndromes occur during Vira mia.
  33. So it's an acute infection and these neurological processes occur
  34. while the virus is still in the patient's system.
  35. And it's estimated about 13% of hospitalized patients.
  36. How these, even though as we'll talk about later, that
  37. number seems incredibly low depending on your definition of nervous
  38. system involvement I guess.
  39. So let's talk about some of the power infectious complications,
  40. one of which is an AS miA.
  41. That's the one that may herald the disease.
  42. And the path of physiology involves the sustenance, ocular or
  43. support cells of the nasal mucosa which are rich in
  44. the angiotensin converting enzyme to receptors just like the rest
  45. of the respiratory system.
  46. And so it activates macrophages.
  47. And there is diffuse inflammation which affects the olfactory bulb.
  48. As it turns out, there's no actual direct viral involvement
  49. of the olfactory vole.
  50. Now when you can't smell which is what a nausea
  51. means. Of course you also can't taste because you depend
  52. on your smell in order to taste.
  53. Well most of these people actually resolve some people don't
  54. get their full smell back and that's called parasomnia which
  55. also impairs of course their taste.
  56. Um So we see macrophages but no viruses in the
  57. olfactory bulb And it's estimated about 40-60% of people with
  58. covid infections develop an AS mia.
  59. Next very common, relatively speaking involvement is that of a
  60. stroke. And about probably up to 5% of hospitalized COVID
  61. patients may suffer from a stroke.
  62. And the reason for that is we have to invoke
  63. dr vishal because thrombosis is of course depends on his
  64. triad. So there is vascular endothelial injury, there are alterations
  65. in the constitution of blood which make it hyper co
  66. arguable and the patient themselves or himself or herself don't
  67. move around too much.
  68. And so there was clear cut stasis.
  69. So as a result of these processes the vascular injury,
  70. the hyper kogel ability and the alteration in blood flow.
  71. One ends up getting a lot of thrombosis which can
  72. either be strokes or venous thrombosis.
  73. Now the SARS covid can get to the vascular areas
  74. either hematology nicely of course or via neuronal propagation.
  75. I either is the vagal nerve and there are viral
  76. particles that have been found in the Gi tract and
  77. also they may travel retrograde axonal transport by the olfactory
  78. bulb. Now the diagram on the right shows how there
  79. are a stew inhibitors in the end of helium which
  80. then caused the inflammation and endothelial itis, if that's a
  81. word, I don't know, I'm gonna look that up.
  82. Um And these changes can result not only in thrombosis
  83. but in alteration in the blood brain barrier such that
  84. proteins can seep through to the brain as well as
  85. blood. So not only does one see ischemic infarct, but
  86. there is hemorrhage that is possible as well.
  87. And so people who have risk factors such as vascular
  88. disease probably have a higher percentage probability of developing strokes,
  89. but people who are otherwise healthy with no known risk
  90. factors can present with strokes.
  91. And those strokes can be multiple, multiple arterial inclusions.
  92. There can be a intracranial venous thrombosis, leading to raising
  93. your cranial pressure in pseudo tumor cerebro.
  94. I has been described as a complication of covid as
  95. well as these micro hemorrhages.
  96. So when one evaluates a patient in the hospital we'll
  97. talk about a little bit keep in mind that strokes
  98. are very much a possibility to contribute to neurological declines.
  99. Now talking still in the very me a phase, there
  100. are certain immune mediated conditions or syndromes that have been
  101. defined or described.
  102. Now there is a leuco encephalopathy and this may simply
  103. be from hypoxic ischemic cerebral injury.
  104. It's not necessarily an immune mediated process.
  105. But in a patient in the ICU, he was not
  106. responding well who has had severe respiratory involvement.
  107. Certainly this is a consideration that needs evaluation.
  108. Unlike that condition, however, there is one called acute necrotizing
  109. hemorrhagic encephalitis.
  110. I love that name and it is characteristic by bilateral,
  111. equally symmetrical the lamb IQ involvement as well as hemorrhage,
  112. hence the name.
  113. And this condition is certainly found to be mediated by
  114. cytokines. So within the brain macrophages um can produce cytokines
  115. and as a result there is actually a treatment for
  116. that doesn't respond to steroids.
  117. But plasma exchange and I?
  118. Ve have been shown to be effective in helping some
  119. of these patients out and whether or not um all
  120. patients respond is unclear, but it is certainly worth an
  121. attempt Now, of course the virus itself is not neurotrophic.
  122. So mingle encephalitis does not occur as a result of
  123. direct viral involvement of the brain or meninges.
  124. But rather these more immune mediated processes, one of which
  125. doesn't even have a name, but it has an incredible
  126. list of central nervous system involvement, including coma, but you
  127. get movement disorder, several attacks etcetera, etcetera.
  128. Uh and again, this is related to cytokine release.
  129. This sort of harkens back to the old days of
  130. neurology when they had no clue what was going on.
  131. And they simply describe the condition in regards to the
  132. neurological localization and manifestations and they didn't really understand the
  133. path of physiology.
  134. Unlike here where they we do understand a lot more
  135. about the immune system and again this has responded like
  136. the previous syndrome, two cortical steroids or are big.
  137. Alright, so that takes care of the power infectious phase.
  138. Now after that, our weight before I go through that,
  139. I'm sorry.
  140. Um so a lot of patients who have this acute
  141. illness will develop an encephalopathy.
  142. And so how to sort out whether that encephalopathy is
  143. simply metabolic.
  144. Obviously we'll see if there increase create innings or liver
  145. functions are sufficient to cause altered mental status, whether their
  146. respiratory status in and of itself is sufficient to cause
  147. they're altered mental status.
  148. Um but if it's thought that there is more confusion
  149. or delirium or even seizures or comatose beyond what that
  150. can be explained by a metabolic process, derangement.
  151. You'd have to consider whether there was a stroke.
  152. And so an MRI scan looking for strokes are are
  153. one of the other rarer conditions and even consider obtaining
  154. spinal fluid to see whether there is some sort of
  155. immune mediated process.
  156. We would check their Olivo clonal bands there, I.
  157. G. Synthesis rate and ultimately we would want to see
  158. if it would be possible to check a cell site
  159. commentary to see whether this is a T cell mediated
  160. process or B cell or even obtain a side akin
  161. panel to help direct which part of the immune system
  162. needs further either control or boosting.
  163. So um medications can obviously cause a role and this
  164. is the most common manifestation of a neurological process and
  165. when it occurs when there is a delirium or altered
  166. mental status, it certainly prolongs the hospitalization as well as
  167. affecting the overall prognosis of that patient.
  168. In the at least 2/3 of people who developed an
  169. encephalopathy when they are discharged, no longer regain um functional
  170. ah activity.
  171. They are not independent, They can't perform activities of daily
  172. living and so as a clear cut um bad prognostic
  173. indicator. Now we can move out of the power infectious
  174. and let's go to the post viral syndromes that have
  175. been recognized and these may occur in any part of
  176. the nervous system.
  177. So we'll talk about the peripheral nervous system, central and
  178. neuro muscular in the peripheral nervous system.
  179. After they resolve the acute infection, they may develop diffuse
  180. weakness and they may have either characteristic or classical type
  181. dim illuminating gingham beret or have an axonal Gamber.
  182. And even the so called Miller fisher variant of Dion
  183. bar A has been described as you all, of course.
  184. Remember, Miller fisher is characterized by a triad of optima
  185. plea J ataxia and he reflects you and accordingly there
  186. are cranial neuropathy, these ridiculous sympathies and flexible these which
  187. have been described after the acute infectious processes over similarly.